Patents by Inventor Ernest S. Paight

Ernest S. Paight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?3 agonists and uses thereof
    Patent number: 6939867
    Abstract: Sulfamide compounds having formula (I) are described as well as their use in the treatment of diseases dependent on the signaling pathways associated with ?-adrenergic receptors, such as obesity, diabetes, hypertension, gastrointestinal hypo- or hyper-motility and cardiovascular diseases
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: September 6, 2005
    Assignee: Pfizer Inc.
    Inventors: Robert L. Dow, Ernest S. Paight
  • Beta3 agonists and uses thereof
    Publication number: 20020128247
    Abstract: Sulfamide compounds having formula (I) are described as well as their use in the treatment of diseases dependent on the signaling pathways associated with &bgr;-adrenergic receptors, such as obesity, diabetes, hypertension, gastrointestinal hypo- or hyper-motility and cardiovascular diseases.
    Type: Application
    Filed: February 28, 2002
    Publication date: September 12, 2002
    Inventors: Robert L. Dow, Ernest S. Paight